Fritextsökning
Innehållstyper
-
Finnish-Dutch engineering cooperation continues
The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Age essential when testing drugs
Anders Rane has been arguing that genes and age are both important factors in understanding how medicines affect individuals. Only last year, the EU established...
-
”Vi vill inte ha rättvisa”
Det handlar inte om rättvisa, målet är inte 50 procent kvinnor i styrelser och bolagsledningar för att det ska vara rättvist, utan för att vi har så mycket att ...
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...
-
Oslo Cancer Cluster
Cancer is, of course, the focus for this Oslo-based cluster, which is solely dedicated to cancer treatment and diagnostics. Oslo cancer cluster is also a part o...
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
Anna-Karin Maltais ny vetenskaplig chef hos XNK Therapeutics
Det svenska immunterapibolaget XNK Therapeutics tar in Anna-Karin Maltais som CSO. Hon tillträder tjänsten den 17 oktober.
-
SDU professor helps EU
Mette Præst Knudsen from the University of Southern Denmark, SDU, has been appointed as an expert member in an EU politics group.
-
Nytt coronavirus upptäckt hos fladdermöss – tog sig förbi vaccin
Ett nytt coronavirus i levande fladdermöss har upptäckts av forskare i USA. Enligt forskarna är viruset resistent mot befintliga covidvaccin.
-
Ryskt universitet stängs av från FIP efter öppet brev till stöd för Putins krig
Ett universitet i S:t Petersburg stängs av från FIP efter ett öppet brev från rektorn till stöd för Rysslands krig i Ukraina. Hundratals rektorer har skrivit under brevet.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Cyxone skjuter på patientrekrytering och listbyte
Forskningsbolaget Cyxone skjuter på prognosen för patientinkludering för fas 2-studien med Rabeximod och avvaktar med tidigare aviserade planer på ett listbyte ...
-
IRW Consulting is seeking Clinical Research Associates (CRAs) on positions located in Stockholm
-
Go ahead for leg wound study
Tripep starts a phase II-study of their wound healing joint venture project.
-
Cancer cells cheat suicide call
Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of...
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Your partnering tool - step by step
Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.